News

Learn everything you need to know about Anastrozole-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions ...
As with other drugs, Arimidex can cause side effects, such as headache and bone pain. Arimidex is approved to treat the following types of breast cancer in females* who have gone through menopause ...
Women already taking the drug have described it as a 'gift' that allows them to go about their lives with less worry about a potential cancer diagnosis. But what exactly is anastrozole?
Objective: To determine the recommended clinical dosage in Japan of a new aromatase inhibitor, anastrozole. Design and Setting: A randomised, nonblinded, dose-comparative clinical pharmacology ...
The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that ...
Anastrozole was first recommended as a preventive ... uptake has remained low. Now the drug has been licensed by the Medicines and Healthcare products Regulatory Agency as a preventive option ...
Nearly 300,000 women in England will be offered a preventative pill to help them avoid breast cancer. The drug, anastrozole, has been available for years as a breast cancer treatment, and had ...
Anastrozole, a daily pill to prevent breast cancer, will now be available to thousands of more women in the UK after being cleared for wider use. The drug has been used to treat hormone-driven ...
Post-menopausal women in the UK who are at a higher risk of breast cancer may soon have wider access to a medicine called anastrozole to reduce their chance of developing it. The drug, which is ...
Share on Pinterest Anastrozole can reduce breast cancer risk after menopause, but does it come with its own risks? Image credit: shironosov/Getty Images. A drug used as a breast cancer treatment ...
Tens of thousands of women in England could benefit from a drug that helps prevent breast cancer. Anastrozole, used for many years to treat the disease, has now been licensed as a preventative option.
In addition, the results from the early phase II study in patients with breast cancer demonstrated a superior clinical efficacy of anastrozole at the 1mg daily dose compared with the 0.5mg daily dose.